{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:29:32Z","timestamp":1790501372900,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T00:00:00Z","timestamp":1532649600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["contract number: 30942839"],"award-info":[{"award-number":["contract number: 30942839"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1652-6","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T09:36:47Z","timestamp":1532684207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay"],"prefix":"10.1186","volume":"20","author":[{"given":"Maurizio","family":"Cutolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Soldano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia Chiara","family":"Trombetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Contini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ruaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Sulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Scabini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Stratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Paolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Pizzorni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Brizzolara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,27]]},"reference":[{"key":"1652_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nrrheum.2014.222","volume":"11","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Distler O. Systemic sclerosis in 2014: advances in cohort enrichment shape future of trial design. Nat Rev Rheumatol. 2015;11:72\u20134.","journal-title":"Nat Rev Rheumatol"},{"key":"1652_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.berh.2012.01.011","volume":"26","author":"A Balbir-Gurman","year":"2012","unstructured":"Balbir-Gurman A, Braun-Moscovici Y. Scleroderma: new aspects in pathogenesis and treatment. Best Pract Res Clin Rheumatol. 2012;26:13\u201324.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1652_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","volume":"8","author":"S Bhattacharyya","year":"2012","unstructured":"Bhattacharyya S, Wei J, Varga J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol. 2012;8:42\u201354.","journal-title":"Nat Rev Rheumatol"},{"key":"1652_CR4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3899\/jrheum.141070","volume":"42","author":"M Cutolo","year":"2015","unstructured":"Cutolo M, Montagna P, Brizzolara R, Smith V, Alessandri E, Villaggio B, et al. Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts. J Rheumatol. 2015;42:456\u201363.","journal-title":"J Rheumatol"},{"key":"1652_CR5","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1136\/annrheumdis-2013-204516","volume":"74","author":"M Tomcik","year":"2015","unstructured":"Tomcik M, Palumbo-Zerr K, Zerr P, Avouac J, Dees C, Sumova B, et al. S100A4 amplifies TGF-\u03b2-induced fibroblast activation in systemic sclerosis. Ann Rheum Dis. 2015;74:1748\u201355.","journal-title":"Ann Rheum Dis"},{"key":"1652_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1582-4934.2007.00213.x","volume":"12","author":"B Eyden","year":"2008","unstructured":"Eyden B. The myofibroblasts: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med. 2008;12:22\u201337.","journal-title":"J Cell Mol Med"},{"key":"1652_CR7","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","volume":"170","author":"B Hinz","year":"2007","unstructured":"Hinz B, Phan SH, Thannickal VJ, Galli A, Bothaton-Piallat ML, Gabbiani G. The myofibroblasts: one function, multiple origin. Am J Pathol. 2007;170:1807\u201316.","journal-title":"Am J Pathol"},{"key":"1652_CR8","doi-asserted-by":"publisher","unstructured":"Brenner DA, Kisseleva T, Scholten D, Paik TH, Iwaisako K, Inokuchi S, et al. Origin of myofibroblasts in liver fibrosis. Fibrogenesis Tissue Repair. 2012;5(Suppl 1) https:\/\/doi.org\/10.1186\/1755-1536-5-S1-S17.","DOI":"10.1186\/1755-1536-5-S1-S17."},{"issue":"Suppl 1","key":"1652_CR9","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.2119\/molmed.2015.00043","volume":"21","author":"R Bucala","year":"2015","unstructured":"Bucala R. Fibrocytes at 20 years. Mol Med. 2015;21(Suppl 1):S3\u20135. https:\/\/doi.org\/10.2119\/molmed.2015.00043.","journal-title":"Mol Med"},{"key":"1652_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1089\/wound.2011.0310","volume":"1","author":"G Grieb","year":"2012","unstructured":"Grieb G, Bucala R. Fibrocytes in fibrotic diseases and wound healing. Adv Wound Care (New Rochelle). 2012;1:36\u201340.","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"1652_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.exphem.2010.03.004","volume":"38","author":"EL Herzoga","year":"2010","unstructured":"Herzoga EL, Bucala R. Fibrocytes in health and disease. Exp Hematol. 2010;38:548\u201356.","journal-title":"Exp Hematol"},{"key":"1652_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12931-017-0623-9","volume":"18","author":"SA Just","year":"2017","unstructured":"Just SA, Lindegaard H, Hejb\u00f8l EK, Davidsen JR, Bjerring N, Hansen SWK, et al. Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in rheumatoid arthritis. Respir Res. 2017;18:141.","journal-title":"Respir Res"},{"key":"1652_CR13","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1189\/jlb.0309132","volume":"86","author":"RM Strieter","year":"2009","unstructured":"Strieter RM, Keeley EC, Hughes MA, Burdick MD, Mehrad B. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol. 2009;86:1111\u20138.","journal-title":"J Leukoc Biol"},{"key":"1652_CR14","doi-asserted-by":"publisher","unstructured":"Liu Y, Qingjuan S, Gao Z, Deng C, Wang Y, Guo C. Circulating fibrocytes are involved in inflammation and leukocyte trafficking in neonates with necrotizing enterocolitis. Medicine (Baltimore). 2017; https:\/\/doi.org\/10.1097\/MD.0000000000007400 .","DOI":"10.1097\/MD.0000000000007400"},{"key":"1652_CR15","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaci.2015.08.043","volume":"137","author":"I Dupin","year":"2016","unstructured":"Dupin I, Allard B, Ozier A, Maurat E, Ousova O, Delbrel E, et al. Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4-dependent pathway. J Allergy Clin Immunol. 2016;137:1036\u201342.","journal-title":"J Allergy Clin Immunol"},{"key":"1652_CR16","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s10067-006-0461-5","volume":"26","author":"R Russo","year":"2007","unstructured":"Russo R, Medbury H, Guiffre A, Englert H, Manolios N. Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma. Clin Rheumatol. 2007;26:1136\u201341.","journal-title":"Clin Rheumatol"},{"key":"1652_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.biocel.2009.10.014","volume":"42","author":"EC Keeleya","year":"2010","unstructured":"Keeleya EC, Mehradb B, Strieter RM. Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol. 2010;42:535\u201342.","journal-title":"Int J Biochem Cell Biol"},{"key":"1652_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nri2990","volume":"11","author":"RA Reilkoff","year":"2011","unstructured":"Reilkoff RA, Bucala R, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol. 2011;11:427\u201335.","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 1","key":"1652_CR19","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1755-1536-5-S1-S6","volume":"5","author":"A Blakaj","year":"2012","unstructured":"Blakaj A, Bucala R. Fibrocytes in health and disease. Fibrogenesis Tissue Repair. 2012;5(Suppl 1):S6. https:\/\/doi.org\/10.1186\/1755-1536-5-S1-S6 .","journal-title":"Fibrogenesis Tissue Repair"},{"key":"1652_CR20","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.94.12.6307","volume":"94","author":"J Chesney","year":"1997","unstructured":"Chesney J, Bacher M, Bender A, Bucala R. The peripheral blood fibrocyte is a potent antigen presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci. 1997;94:6307\u201312.","journal-title":"Proc Natl Acad Sci"},{"key":"1652_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/ar2865","volume":"11","author":"M Cutolo","year":"2009","unstructured":"Cutolo M, Soldano S, Montagna P, Sulli A, Seriolo B, Villaggio B, et al. CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production. Arthritis Res Ther. 2009;11:176\u201385.","journal-title":"Arthritis Res Ther"},{"key":"1652_CR22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3899\/jrheum.120866","volume":"40","author":"R Brizzolara","year":"2013","unstructured":"Brizzolara R, Montagna P, Soldano S, Cutolo M. Rapid interaction between CTLA4-Ig (abatacept) and synovial macrophages from patients with rheumatoid arthritis. J Rheumatol. 2013;40:738\u201340.","journal-title":"J Rheumatol"},{"key":"1652_CR23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/art.37787","volume":"65","author":"M Bonelli","year":"2013","unstructured":"Bonelli M, Ferner E, G\u00f6schl L, Bl\u00fcml S, Hladik A, Karonitsch T, et al. Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis. Arthritis Rheum. 2013;65:599\u2013607.","journal-title":"Arthritis Rheum"},{"key":"1652_CR24","first-page":"250","volume":"33","author":"M Cutolo","year":"2015","unstructured":"Cutolo M, Montagna P, Soldano S, Contini P, Paolino S, Pizzorni S, et al. CTLA4-IG\/CD86 interaction in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression. Clin Exp Rheumatol. 2015;33:250\u20134.","journal-title":"Clin Exp Rheumatol"},{"key":"1652_CR25","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1136\/annrheumdis-2015-208213","volume":"75","author":"M Ponsoye","year":"2016","unstructured":"Ponsoye M, Frantz C, Ruzehaji N, Nicco C, Elhai M, Ruiz B, et al. Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis. Ann Rheum Dis. 2016;75:2142\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1652_CR26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00393-013-1157-2","volume":"72","author":"M Cutolo","year":"2013","unstructured":"Cutolo M. Disease modification in systemic sclerosis. Do integrated approaches offer new challenges? Z Rheumatol. 2013;72:326\u20138.","journal-title":"Z Rheumatol"},{"key":"1652_CR27","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360:1989\u20132003.","journal-title":"N Engl J Med"},{"key":"1652_CR28","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"1652_CR29","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1136\/ard.2006.066530","volume":"66","author":"L Czirj\u00e1k","year":"2007","unstructured":"Czirj\u00e1k L, Nagy Z, Aringer M, Riemekasten G, Matucci-Cerinic M, Furst DE, EUSTAR. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis. 2007;66:966\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1652_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jim.2009.09.011","volume":"351","author":"D Pilling","year":"2009","unstructured":"Pilling D, Vakil V, Gomer RH. Improved serum-free culture conditions for the differentiation of human and murine fibrocytes. J Immunol Methods. 2009;351:62\u201370.","journal-title":"J Immunol Methods"},{"key":"1652_CR31","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1136\/ard.2010.142489","volume":"70","author":"C Beyer","year":"2011","unstructured":"Beyer C, Distler JH, Allanore Y, Aringer M, Avouac J, Czirijak L, EUSTAR Biobanking Group, et al. EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research. Ann Rheum Dis. 2011;70:1178\u201382.","journal-title":"Ann Rheum Dis"},{"key":"1652_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C (T)) method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"1652_CR33","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1172\/JCI200420997","volume":"114","author":"RJ Phillips","year":"2004","unstructured":"Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004;114:438\u201346.","journal-title":"J Clin Invest"},{"key":"1652_CR34","doi-asserted-by":"publisher","first-page":"7661","DOI":"10.4049\/jimmunol.0803783","volume":"183","author":"FC Rau","year":"2009","unstructured":"Rau FC, Baumgarth N. CD86-1\/2 (CD80\/CD86) direct signaling to B cells enhances IgG secretion. J Immunol. 2009;183:7661\u201371.","journal-title":"J Immunol"},{"key":"1652_CR35","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1136\/ard.2007.080713","volume":"67","author":"R Axnamm","year":"2008","unstructured":"Axnamm R, Herman S, Zaiss M, Franz S, Polzer K, Zwerina J, et al. CTLA-4 directly inhibit OC. Ann Rheum Dis. 2008;67:1603\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1652_CR36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/08916930902832470","volume":"42","author":"B Vogt","year":"2009","unstructured":"Vogt B, Warncke M, Micheel B, Sheriff A. Lentiviral gene transfer of CTLA4 generates B cells with reduced costimulatory properties. Autoimmunity. 2009;42:380\u20139.","journal-title":"Autoimmunity"},{"key":"1652_CR37","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1182\/blood-2009-11-255026","volume":"116","author":"H Li","year":"2010","unstructured":"Li H, Hong S, Qian J, Zheng Y, Yang J, Yi Q. Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells. Blood. 2010;116:210\u20137.","journal-title":"Blood"},{"key":"1652_CR38","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.4049\/jimmunol.158.10.4921","volume":"158","author":"K Pechhold","year":"1997","unstructured":"Pechhold K, Patterson NB, Craighead N, Lee KP, June CH, Harlan DM. Inflammatory cytokines IFN-gamma plus TNF-alpha induce regulated expression of CD80 (B7-1) but not CD86 (B7-2) on murine fibroblasts. J Immunol. 1997;158:4921\u20139.","journal-title":"J Immunol"},{"issue":"1","key":"1652_CR39","doi-asserted-by":"publisher","first-page":"R35","DOI":"10.1186\/ar3267","volume":"13","author":"JT Van Praet","year":"2011","unstructured":"Van Praet JT, Smith V, Haspeslagh M, Degryse N, Elewaut D, De Keyser F. Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study. Arthritis Res Ther. 2011;13(1):R35.","journal-title":"Arthritis Res Ther."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1652-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1652-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1652-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:22:21Z","timestamp":1693786941000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1652-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,27]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1652"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1652-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,27]]},"assertion":[{"value":"20 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of the IRCCS San Martino Polyclinic of Genoa (protocol number 273-REG-2015). All SSc patients and HSs provided informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MC has obtained research funds from BMS, Actelion, Celgene, Boehringer. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"157"}}